Vaccine
Agalax Uno
Inactivated vaccine against contagious agalactia as suspension for injection
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
| Active ingredient(s) | Posology* | Waiting time | Packaging |
|---|---|---|---|
– Inactivated mycoplasma agalactiae, strain N84 | Subcutaneous administration | Zero days | 50 mL (25 doses) 100 mL (50 doses) 250 mL (125 doses) |
Country Availability
Cyprus, Greece, Saudi Arabia, Spain.
If your country is not listed, please contact our export team.
Active ingredient(s)
Inactivated mycoplasma agalactiae, strain N84 …………………………………………………….≥ 1/20* GI
* Antibody titre obtained by the growth inhibition technique after administration of a dose in lambs.
Indications
For active immunization of sheep and goats against contagious agalactia produced by Mycoplasma agalactiae to prevent infection and reduce clinical signs and/or lesions from the disease
Onset of immunity: one month after administration of the second dose
Duration of immunity: four months after administration of the second dose
Posology
2 ml/animal.
In healthy or undamaged herds, one application to all breeding stock, males and females and to all replacement animals from 2-3 months of age.
In infected herds or herds with a severe risk of infection, administer a second dose 2-4 weeks after the first.
In general, revaccination is recommended every 4-6 months, depending on infection pressure.
Waiting time
Zero Days
Packaging
Containers with 100 mL (50 doses) and 250 mL (125 doses).
With veterinary prescription.
Registry no.: 2567 ESP
